Literature DB >> 2555151

A transforming function of the BARF1 gene encoded by Epstein-Barr virus.

M X Wei1, T Ooka.   

Abstract

We report a new rodent cell-transforming gene, presumably involved in viral replication, encoded by Epstein-Barr virus. We previously showed that the corresponding open reading frame BARF1 is transcribed before the onset of viral DNA synthesis, and translated into a 33 kd early polypeptide (p33). Here we show that recombinant plasmids containing the BARF1 induce morphological change, anchorage-independent growth and tumorigenic transformation of established mouse fibroblast lines. The BARF1-transformed cells and the tumour tissues isolated from new-born rats after injection of such transformed cell both express p33. Transforming activity was obtained from either the genomic fragment or the cDNA sequence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555151      PMCID: PMC401352          DOI: 10.1002/j.1460-2075.1989.tb08438.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells.

Authors:  M A Bedell; K H Jones; L A Laimins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target.

Authors:  J M Cameron; I McDougall; H S Marsden; V G Preston; D M Ryan; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

3.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

Review 4.  Aspects of the EB virus.

Authors:  M A Epstein
Journal:  Adv Cancer Res       Date:  1970       Impact factor: 6.242

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 6.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 7.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

8.  Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells.

Authors:  C X Zhang; G Decaussin; J Daillie; T Ooka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

Authors:  V R Baichwal; B Sugden
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

Review 10.  Role of epithelium in EBV persistence and pathogenesis of B-cell tumours.

Authors:  M J Allday; D H Crawford
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

View more
  39 in total

1.  Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.

Authors:  J I Cohen; K Lekstrom
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

3.  Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells.

Authors:  Richeng Jiang; Giulia Cabras; Wang Sheng; Yixin Zeng; Tadamasa Ooka
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

4.  Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.

Authors:  Mee Soo Chang; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

5.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines.

Authors:  Z P Teng; T Ooka; D P Huang; Y Zeng
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 8.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

9.  Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1.

Authors:  Jonathan Elegheert; Nathalie Bracke; Philippe Pouliot; Irina Gutsche; Alexander V Shkumatov; Nicolas Tarbouriech; Kenneth Verstraete; Anaïs Bekaert; Wim P Burmeister; Dmitri I Svergun; Bart N Lambrecht; Bjorn Vergauwen; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

Review 10.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.